{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:54:41Z","timestamp":1788573281294,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["03-006-2021-T019"],"award-info":[{"award-number":["03-006-2021-T019"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ERC-2022-ADG"],"award-info":[{"award-number":["ERC-2022-ADG"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101097983"],"award-info":[{"award-number":["101097983"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020140","name":"Amsterdam Neuroscience","doi-asserted-by":"publisher","award":["813294"],"award-info":[{"award-number":["813294"]}],"id":[{"id":"10.13039\/501100020140","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["91719305"],"award-info":[{"award-number":["91719305"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.neurot.2025.e00736","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:43:47Z","timestamp":1757519027000},"page":"e00736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The polyunsaturated fatty acid and oxylipin plasma signature of aneurysmal subarachnoid haemorrhage, case-control study"],"prefix":"10.1016","volume":"22","author":[{"given":"M.A.","family":"Franssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Tjerkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Heijink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Rotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Verbaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van Bavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.P.","family":"Vandertop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Giera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.A.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neurot.2025.e00736_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/01.STR.31.5.1054","article-title":"A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study","volume":"31","author":"Ingall","year":"2000","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00736_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nec.2009.10.014","article-title":"Outcome and cost of aneurysmal subarachnoid hemorrhage","volume":"21","author":"le Roux","year":"2010","journal-title":"Neurosurg Clin"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00736_bib3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/STROKEAHA.122.040072","article-title":"Early brain injury after subarachnoid hemorrhage: incidence and mechanisms","volume":"54","author":"Lauzier","year":"2023","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00736_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/bja\/aes264","article-title":"Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm","volume":"109","author":"Rowland","year":"2012","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00736_bib5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/jcm12031015","article-title":"Pathophysiology of early brain injury and its association with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a review of current literature","volume":"12","author":"Alsbrook","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.neurot.2025.e00736_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.33393\/jcb.2023.2502","article-title":"Laboratory biomarkers of delayed cerebral ischemia following subarachnoid hemorrhage: a systematic review","volume":"12","author":"Tjerkstra","year":"2023","journal-title":"J Circ Biomark"},{"key":"10.1016\/j.neurot.2025.e00736_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.wneu.2017.07.114","article-title":"Emerging markers of early brain injury and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage","volume":"107","author":"Al-Mufti","year":"2017","journal-title":"World Neurosurg"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00736_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1227\/00006123-198809000-00005","article-title":"Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: experimental study on the pathogenesis of cerebral vasospasm","volume":"23","author":"Seifert","year":"1988","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neurot.2025.e00736_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2016.02.020","article-title":"Omega-3 polyunsaturated fatty acids mitigate blood\u2013brain barrier disruption after hypoxic\u2013ischemic brain injury","volume":"91","author":"Zhang","year":"2016","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00736_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbalip.2006.03.014","article-title":"Oxidative stress and arachidonic acid mobilization","volume":"1761","author":"Balboa","year":"2006","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00736_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Gabbs","year":"2015","journal-title":"Adv Nutr"},{"key":"10.1016\/j.neurot.2025.e00736_bib12","series-title":"Clinical metabolomics: methods and protocols","author":"Giera","year":"2018"},{"key":"10.1016\/j.neurot.2025.e00736_bib13","article-title":"Systemic metabolic alterations after aneurysmal subarachnoid hemorrhage: a plasma metabolomics approach","author":"Yang","year":"2025","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00736_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/STROKEAHA.111.636035","article-title":"Free fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage","volume":"43","author":"Badjatia","year":"2012","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00736_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jneumeth.2004.11.015","article-title":"Identification and quantification of the hydroxyeicosatetraenoic acids, 20-HETE and 12-HETE, in the cerebrospinal fluid after subarachnoid hemorrhage","volume":"144","author":"Poloyac","year":"2005","journal-title":"J Neurosci Methods"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00736_bib16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/jcbfm.2015.75","article-title":"20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patients","volume":"35","author":"Donnelly","year":"2015","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00736_bib17","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/STROKEAHA.110.605816","article-title":"Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage","volume":"42","author":"Crago","year":"2011","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00736_bib18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1179\/016164106X152016","article-title":"Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm","volume":"28","author":"Roman","year":"2006","journal-title":"Neurol Res"},{"key":"10.1016\/j.neurot.2025.e00736_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brainres.2009.12.031","article-title":"Subarachnoid hemorrhage induces enhanced expression of thromboxane A2 receptors in rat cerebral arteries","volume":"1316","author":"Ansar","year":"2010","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00736_bib20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/STROKEAHA.115.011223","article-title":"Lipoxin A4 reduces inflammation through formyl peptide receptor 2\/p38 MAPK signaling pathway in subarachnoid hemorrhage rats","volume":"47","author":"Guo","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2025.e00736_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.wneu.2016.12.018","article-title":"\u03c9-3 fatty acids ethyl esters suppress cerebral vasospasm and improve clinical outcome following aneurysmal subarachnoid hemorrhage","volume":"99","author":"Nakagawa","year":"2017","journal-title":"World Neurosurg"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00736_bib22","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2025.e00736_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2022.100112","article-title":"Prostaglandin-E2 levels over the course of glyceryl trinitrate provoked migraine attacks","volume":"13","author":"Harder","year":"2023","journal-title":"Neurobiol Pain"},{"key":"10.1016\/j.neurot.2025.e00736_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fmolb.2015.00004","article-title":"A data preprocessing strategy for metabolomics to reduce the mask effect in data analysis","volume":"2","author":"Yang","year":"2015","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00736_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005973","article-title":"GSimp: a Gibbs sampler based left-censored missing value imputation approach for metabolomics studies","volume":"14","author":"Wei","year":"2018","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00736_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc B"},{"key":"10.1016\/j.neurot.2025.e00736_bib27","first-page":"1165","article-title":"The control of the false discovery rate in multiple testing under dependency","author":"Benjamini","year":"2001","journal-title":"Ann Stat"},{"key":"10.1016\/j.neurot.2025.e00736_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jchromb.2014.03.015","article-title":"Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product","volume":"964","author":"Porro","year":"2014","journal-title":"J Chromatogr B"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00736_bib29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1194\/jlr.D081414","article-title":"Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI\/HRMS","volume":"59","author":"Mazaleuskaya","year":"2018","journal-title":"JLR (J Lipid Res)"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00736_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3171\/jns.2002.97.2.0272","article-title":"Free fatty acids in human cerebrospinal fluid following subarachnoid hemorrhage and their potential role in vasospasm: a preliminary observation","volume":"97","author":"Pilitsis","year":"2002","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00736_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1385\/JMN:16:2-3:195","article-title":"Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro","volume":"16","author":"Moore","year":"2001","journal-title":"J Mol Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00736_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0006-8993(99)01752-7","article-title":"Lactate and free fatty acids after subarachnoid hemorrhage","volume":"840","author":"Gewirtz","year":"1999","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00736_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12028-014-0011-y","article-title":"Protective role of P450 epoxyeicosanoids in subarachnoid hemorrhage","volume":"22","author":"Siler","year":"2015","journal-title":"Neurocritical Care"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00736_bib34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1471-4159.1983.tb09071.x","article-title":"Identification of 5-hydroxy eicosatetraenoic acid in cerebrospinal fluid after subarachnoid hemorrhage","volume":"41","author":"Suzuki","year":"1983","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2025.e00736_bib35","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3389\/fneur.2020.00983","article-title":"20-HETE enzymes and receptors in the neurovascular unit: implications in cerebrovascular disease","volume":"11","author":"Gonzalez-Fernandez","year":"2020","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00736_bib36","doi-asserted-by":"crossref","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta","year":"2014","journal-title":"Indian J Anaesth"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00736_bib37","first-page":"2422","article-title":"Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury","volume":"46","author":"Mullane","year":"1987","journal-title":"Fed Proc"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00736_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(95)11482-C","article-title":"Localization of 12-lipoxygenase mRNA in cultured oligodendrocytes and astrocytes by in situ reverse transcriptase and polymerase chain reaction","volume":"189","author":"Bendani","year":"1995","journal-title":"Neurosci Lett"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00736_bib39","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/01.ATV.0000186181.19909.a6","article-title":"12\/15-Lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-\u03bab","volume":"25","author":"Bolick","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.neurot.2025.e00736_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2024.102631","article-title":"12-Hydroxyeicosatetraenoic acid is the only enzymatically produced HETE increased under brain ischemia","volume":"202","author":"Golovko","year":"2024","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00736_bib41","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.jcbfm.9600494","article-title":"Soluble epoxide hydrolase: a novel therapeutic target in stroke","volume":"27","author":"Zhang","year":"2007","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"7684","key":"10.1016\/j.neurot.2025.e00736_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature25013","article-title":"Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy","volume":"552","author":"Hu","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00736_bib43","doi-asserted-by":"crossref","first-page":"H1311","DOI":"10.1152\/ajpheart.00380.2011","article-title":"19,20-EpDPE, a bioactive CYP450 metabolite of DHA monoacyglyceride, decreases Ca2+ sensitivity in human pulmonary arteries","volume":"301","author":"Morin","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2-4","key":"10.1016\/j.neurot.2025.e00736_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/CH-2012-1614","article-title":"Effect of cytochrome P450-dependent epoxyeicosanoids on Ristocetin-induced thrombocyte aggregation","volume":"52","author":"Jung","year":"2012","journal-title":"Clin Hemorheol Microcirc"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00736_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12028-016-0292-4","article-title":"The role of platelet activation and inflammation in early brain injury following subarachnoid hemorrhage","volume":"26","author":"Frontera","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.neurot.2025.e00736_bib46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.brainres.2014.11.059","article-title":"Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease","volume":"1597","author":"Liu","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.neurot.2025.e00736_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jare.2017.11.004","article-title":"Arachidonic acid: physiological roles and potential health benefits - a review","volume":"11","author":"Tallima","year":"2018","journal-title":"J Adv Res"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00736_bib48","article-title":"Overconsumption of omega-6 polyunsaturated fatty acids (PUFAs) versus deficiency of omega-3 PUFAs in modern-day diets: the disturbing factor for their \u201cbalanced antagonistic metabolic functions\u201d in the human body","volume":"2021","author":"Mariamenatu","year":"2021","journal-title":"J Lipids"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00736_bib49","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1007\/s00701-023-05864-4","article-title":"What are the predictors of delayed cerebral ischaemia (DCI) after aneurysmal subarachnoid haemorrhage? An up-to-date systematic review","volume":"165","author":"Whittle","year":"2023","journal-title":"Acta Neurochir"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00736_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12028-023-01929-5","article-title":"Aneurysmal subarachnoid hemorrhage and sex differences: analysis of epidemiology, outcomes, and risk factors","volume":"41","author":"Peng","year":"2024","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.neurot.2025.e00736_bib51","article-title":"Neurofilament light chain and S100B serum levels are associated with disease severity and outcome in patients with aneurysmal subarachnoid hemorrhage","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Neurol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:35:04Z","timestamp":1763638504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1878747925002144"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00736","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The polyunsaturated fatty acid and oxylipin plasma signature of aneurysmal subarachnoid haemorrhage, case-control study","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00736"}}